Event Highlights
News from Bayer
January 27, 2023
Not intended for U.S. and UK Media
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
January 19, 2023
Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection
January 10, 2023
Not intended for U.S. and U.K. Media
Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros
Discover More Investor Resources
